CPBLF Stock Chart & Stats
$16.30
$0.00(0.00%)
At close: 4:00 PM EDT
$16.30
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$10.95 - $19.35
Previous CloseN/A
Volume14.00
Average Volume (3M)0.00
Market Cap
$7.88B
Enterprise Value$12.02K
Total Cash (Recent Filing)$149.70M
Total Debt (Recent Filing)$1.57B
Price to Earnings (P/E)34.2
Beta0.68
Next Earnings
Nov 23, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend Yield1.76%
Share Statistics
EPS (TTM)0.63
Shares Outstanding507,542,540
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.28
Price to Book (P/B)5.93
Price to Sales (P/S)3.04
P/FCF Ratio43.57
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$17.77Price Target Upside9.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.65
Revenue Forecast (FY)$2.59B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthMulti-year revenue growth indicates continued demand across ALS’s testing, inspection and certification activities. Its exposure to environmental, life sciences, food, industrial and commodities customers supports a diversified base of recurring testing needs.
Resilient Operating MarginsImproving EBIT margins and sustained EBITDA profitability point to operating scale and pricing or service-mix resilience. A global laboratory footprint and bundled capabilities can support efficiency and protect profitability over the medium term.
Lower Leverage And Positive Cash FlowMaterial deleveraging strengthens financial flexibility and reduces balance-sheet risk after elevated leverage in prior years. Positive and growing operating cash flow provides internal funding capacity for investment, debt reduction and ongoing customer-service infrastructure.
Bears Say
Earnings VolatilityThe sharp net-margin contraction followed by recovery shows that below-the-line costs or one-off items can materially affect earnings. This makes reported profitability less predictable and could reduce resilience if another disruption or exceptional charge occurs.
Inconsistent Cash ConversionAlthough cash generation is positive, the gap between earnings and free cash flow indicates that working capital, capital expenditure or other cash uses can absorb a significant portion of profits. Persistent weak conversion could constrain deleveraging and reinvestment.
Commodity-cycle ExposureALS’s commodities testing demand can weaken when exploration budgets or mining activity decline, creating cyclical pressure on sample volumes and service revenue. Diversification across environmental and life sciences markets helps, but does not remove this structural exposure.
ALS News
CPBLF FAQ
What was ALS Ltd.’s price range in the past 12 months?
ALS Ltd. lowest stock price was $10.95 and its highest was $19.35 in the past 12 months.
What is ALS Ltd.’s market cap?
ALS Ltd.’s market cap is $7.88B.
When is ALS Ltd.’s upcoming earnings report date?
ALS Ltd.’s upcoming earnings report date is Nov 23, 2026 which is in 74 days.
How were ALS Ltd.’s earnings last quarter?
ALS Ltd. released its earnings results on May 17, 2026. The company reported $0.287 earnings per share for the quarter, beating the consensus estimate of $0.279 by $0.008.
Is ALS Ltd. overvalued?
According to Wall Street analysts ALS Ltd.’s price is currently Undervalued.
Does ALS Ltd. pay dividends?
ALS Ltd. pays a Semiannually dividend of $0.164 which represents an annual dividend yield of 1.76%. See more information on ALS Ltd. dividends here
What is ALS Ltd.’s EPS estimate?
ALS Ltd.’s EPS estimate is 0.3.
How many shares outstanding does ALS Ltd. have?
ALS Ltd. has 507,542,540 shares outstanding.
What happened to ALS Ltd.’s price movement after its last earnings report?
ALS Ltd. reported an EPS of $0.287 in its last earnings report, beating expectations of $0.279. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ALS Ltd.?
Currently, no hedge funds are holding shares in CPBLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ALS Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.77 (9.02% Upside)
$17.77 (9.02% Upside)
Insider Transactions
Sold Shares
Worth $829.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.14%
12-Months-Change
Fundamentals
Return on Equity
1.76%
Trailing 12-Months
Asset Growth
6.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ALS Ltd.
ALS Limited delivers expert technical services globally, specializing in analytical testing, precise measurement, and comprehensive inspection across various sectors. Its operations span continents, encompassing Africa, Asia-Pacific, Europe, the Middle East, North Africa, and the Americas. The organization structures its operations into three core divisions: Life Sciences, Commodities, and Industrial. The Commodities division supports mining and mineral exploration firms by providing a comprehensive suite of services, including assaying, analytical testing, and metallurgy. These offerings cover geochemistry, metallurgy, inspection, and ensuring coal quality standards. Throughout the entire resource lifecycle, from initial exploration and feasibility studies to optimization, production, design, development, trade, and rehabilitation, this segment offers critical testing and advisory solutions. Furthermore, it handles coal sampling, analysis, certification, and evaluations of geological formations, alongside other associated analytical tests. The Life Sciences division focuses on the environmental, food, pharmaceutical, and consumer product sectors, delivering analytical testing, sampling, and remote monitoring. It conducts microbiological, physical, and chemical analyses. Moreover, this segment furnishes crucial analytical data to support consulting and engineering companies, various industries, and governmental bodies. The Industrial segment provides specialized diagnostic testing and engineering solutions tailored for the energy, resources, transportation, and infrastructure industries. It caters to a broad clientele, including asset owners, operational managers, construction firms, and equipment manufacturers across sectors such as power generation, petrochemicals, mining, mineral processing, water management, infrastructure development, and transportation. Established in 1863, the company, originally known as Campbell Brothers Limited, adopted its current name, ALS Limited, in August 2012. Its global operations are directed from its headquarters in Milton, Australia.
CPBLF Company Deck
CPBLF Earnings Call
Q4 2026
0:00 / 0:00
CPBLF Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$17.77
▲(9.02% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Downer EDI Limited
―
Imdex Ltd
―
Monadelphous Group Limited
―
NRW Holdings Limited
―
Ventia Services Group Limited
―
Ownership Overview
0.04% Insiders
5.74% Mutual Funds
0.01% Other Institutional Investors
89.63% Public Companies and
Individual Investors






